Spanish scientists have revealed a new approach which could potentially delay the onset of follicular lymphoma.
One in six people with follicular lymphoma has mutations in the RRAGC gene for the protein RagC. RagC is part of the mTOR nutrient signalling pathway which controls metabolic activity and cell growth.
Researchers, led by Dr Alejo Efeyan of the Metabolism and Cell Signalling Group at the Spanish National Cancer Research Centre, carried out studies with mice to investigate the impact of partially blocking the RagC protein. They found that this approach safely delays the onset of follicular lymphoma. Details appeared in the journal Cell Reports last week.
Previously, the team discovered that mutations in the RR...
4 days ago
Spanish scientists have revealed a new approach which could potentially delay the onset of follicular lymphoma.
One in six people with follicular lymphoma has mutations in the RRAGC gene for the protein RagC. RagC is part of th...
4 days ago
US researchers have made new discoveries which may help avoid unnecessary bone marrow biopsies in African Americans who have naturally reduced white blood cell counts.
The benign genotype, called rs2814778-CC or ‘CC’ for short,...
4 days ago